Asset Dedication, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Asset Dedication, LLC

$1.46 Billion
Q3 2024

A detailed history of Asset Dedication, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Asset Dedication, LLC holds 15 shares of REGN stock, worth $10,717. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 15 -0.0%

Holding current value

$10,717

Previous $15,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $10,386 - $12,665	15 New	15 $12,000
Q1 2022 Apr 21, 2022	SELL	$595.12 - $698.43 $10,117 - $11,873	-17 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$574.03 - $680.96 $9,758 - $11,576	17 New	17 $10,000
Q3 2020 Oct 20, 2020	SELL	$544.75 - $658.21 $108,950 - $131,642	-200 Closed	0 $0
Q2 2020 Aug 24, 2020	BUY	$493.32 - $643.92 $98,664 - $128,783	200 New	200 $125,000
Q4 2019 Jan 31, 2020	SELL	$274.13 - $376.51 $4,660 - $6,400	-17 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$273.46 - $318.39 $5,742 - $6,686	-21 Reduced 55.26%	17 $5,000
Q2 2019 Jul 23, 2019	SELL	$299.6 - $414.82 $1,498 - $2,074	-5 Reduced 11.63%	38 $14,000
Q4 2018 Feb 12, 2019	SELL	$335.82 - $403.04 $14,776 - $17,733	-44 Reduced 50.57%	43 $16,000
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $5,122 - $6,209	-18 Reduced 17.14%	87 $32,000
Q1 2018 Apr 19, 2018	SELL	$315.82 - $393.78 $10,106 - $12,600	-32 Reduced 23.36%	105 $39,000
Q4 2017 Jan 17, 2018	SELL	$358.63 - $469.95 $170,349 - $223,226	-475 Reduced 77.61%	137 $50,000
Q3 2017 Oct 18, 2017	BUY	$431.38 - $504.0 $264,004 - $308,448	612	612 $275,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.

Account

Asset Dedication, LLC Regeneron Pharmaceuticals, Inc. Transaction History